Exelixis reported $116.64M in Operating Profit for its fourth fiscal quarter of 2021.


Ok
Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
width
height
Operating Profit Change
Agios Pharmaceuticals AGIO:US $ -102.18M 13.03M
AstraZeneca AZN:LN -292000000 1.38B
Bayer BAYN:GR 2.02B 1.49B
Bluebird Bio BLUE:US $ -135.67M 81.29M
Cytokinetics CYTK:US $ -80.55M 58.85M
Eisai 4523:JP Y 13648M 8149M
Genmab GEN:DC 514M 295M
Immunogen IMGN:US $ -22.85M 11.7M
IONIS PHARMACEUT IONS:US $ 221M 306.85M
Mirati Therapeutics MRTX:US $ -184.22M 12.86M
Nektar Therapeutics NKTR:US $ -112.91M 0.69M
Novartis NOVN:VX 2.56B 671M
Xencor XNCR:US $ 26.47M 65.19M